This trial tests a new treatment called retatrutide (a GLP-1/GIP/glucagon tri-agonist) to assess its effects on kidney function in individuals who are overweight or have obesity and chronic kidney disease
SunDoctors offers professional skin checks to help detect potential issues early and ensure your skin health is on track
While the effects do not occur instantly, you may begin to notice some of the changes below within the first 8 weeks of therapy
Weight loss depends on many factors including medical history, starting weight, nutrition, physical activity, medication adherence, and regular follow-up care
If approved, retatrutide is expected to carry similar class warnings to tirzepatide
Free discreet shipping Delivered to your door, fast and private